Open | - |
Close | - |
Volume / Avg. | 0 / 893.159K |
Day Range | - - - |
52 Wk Range | 125.820 - 335.910 |
Market Cap | $12.029B |
P/E Ratio | 58.395 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 44 |
Short Interest | 4.58% |
Days to Cover | 4.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Insulet (NASDAQ: PODD) through any online brokerage.
Other companies in Insulet’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Abbott Laboratories (NYSE:ABT).
The latest price target for Insulet (NASDAQ: PODD) was reported by Barclays on Monday, February 26, 2024. The analyst firm set a price target for 213.00 expecting PODD to rise to within 12 months (a possible 23.82% upside). 32 analyst firms have reported ratings in the last year.
The stock price for Insulet (NASDAQ: PODD) is $172.02 last updated March 18, 2024 at 4:46 PM EDT.
There are no upcoming dividends for Insulet.
Insulet’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Insulet.
Insulet is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.